TrialMedicine2020
A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4.
Masato Fujioka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
TrialMedicine2020
Masato Fujioka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.